UniSa - IRIS Institutional Research Information System

RAIMONDO, ANNUNZIATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.336
NA - Nord America 959
AS - Asia 574
SA - Sud America 118
AF - Africa 13
OC - Oceania 2
Totale 3.002
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 945
IT - Italia 876
SG - Singapore 275
RU - Federazione Russa 144
CN - Cina 122
BR - Brasile 113
DE - Germania 64
IE - Irlanda 60
IN - India 43
NL - Olanda 41
HK - Hong Kong 40
KR - Corea 32
SE - Svezia 31
FI - Finlandia 23
GB - Regno Unito 19
FR - Francia 15
TR - Turchia 14
VN - Vietnam 14
AT - Austria 12
CH - Svizzera 11
UA - Ucraina 11
JP - Giappone 10
CA - Canada 7
ES - Italia 5
PH - Filippine 5
EG - Egitto 4
IQ - Iraq 4
PK - Pakistan 4
PL - Polonia 4
CZ - Repubblica Ceca 3
MX - Messico 3
PT - Portogallo 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
HR - Croazia 2
TN - Tunisia 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
KE - Kenya 1
LT - Lituania 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.002
Salva come PNG Salva come JPEG
Città #
Chandler 231
Princeton 149
Rome 90
Singapore 89
Milan 75
Moscow 60
Dublin 58
Ann Arbor 52
Naples 52
Hong Kong 36
Salerno 36
Munich 35
Wilmington 34
Ashburn 33
Beijing 25
Amsterdam 21
Seattle 18
Andover 17
Houston 16
Dallas 15
Los Angeles 15
Dong Ket 14
Jacksonville 14
Bari 13
Palermo 13
Turin 13
London 12
The Dalles 12
Turku 12
Woodbridge 12
Nuremberg 11
Cava de' Tirreni 10
Columbus 10
Fisciano 10
Genoa 10
Mumbai 10
Verona 10
Boardman 9
Florence 9
Pune 9
São Paulo 9
Tokyo 9
Albignasego 8
Chennai 8
Padova 8
West Jordan 8
Bologna 7
Guangzhou 7
Sarno 7
Catania 6
Helsinki 6
Lamezia Terme 6
Napoli 6
Acerra 5
Asti 5
Brooklyn 5
Domicella 5
Istanbul 5
Izmir 5
Lappeenranta 5
Marcianise 5
Nanjing 5
New York 5
Ottaviano 5
Redwood City 5
Shanghai 5
Stockholm 5
Atlanta 4
Aversa 4
Barcelona 4
Belo Horizonte 4
Bernezzo 4
Cerignola 4
Cinisello Balsamo 4
Heilbronn 4
Lucca 4
Marseille 4
Messina 4
Modena 4
Norwalk 4
Paris 4
Rimini 4
San Francisco 4
Santa Clara 4
Taranto 4
Vienna 4
Bengaluru 3
Brasília 3
Cape Town 3
Cebu City 3
Clifton 3
Cormano 3
Fairfield 3
Formello 3
Marano Vicentino 3
Mercato San Severino 3
Nellore 3
Parma 3
Pavia 3
Pellezzano 3
Totale 1.653
Salva come PNG Salva come JPEG
Nome #
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 528
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 91
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 76
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 73
Psoriasis and bone damage: the role of phosphodiesterase 4 in the pro-osteoclastogenic process induced by skin inflammation. 72
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 67
Interleukin-33: increasing role in dermatological conditions 62
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 59
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 52
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 52
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 51
Atopic dermatitis: Epidemiology and clinical phenotypes 51
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 47
IL-33 is regulated by TNF-α in normal and psoriatic skin 47
European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions 47
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 44
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 43
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 42
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 41
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 40
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 39
IL-26 in allergic contact dermatitis: Resource in a state of readiness 39
A journey into psoriasis: From the adipose tissue to the skin 39
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 38
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 37
Guselkumab for the treatment of psoriasis 36
Clinical predictors of psoriatic arthritis and osteoclast differentiation 36
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 35
The laboratory role in the assessment of sensitization and irritation potential of cosmetics 35
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 35
A potential prognostic test for bone erosion development in patients with cutaneous predictive sites for psoriatic arthritis 35
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 34
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 34
Human Microbiome: Composition and Role in Inflammatory Skin Diseases 34
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 33
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 33
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 33
Flash-pumped pulsed dye laser for vascular skin lesions: our experience and an overview of the literature 33
RAST: Clinical applications 31
Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review 30
Photosensitivity and cancer immune-targeted therapies 30
The effects of skin psoriasis inflammation on adipose tissue-derived mediators and viceversa 30
IL-26: A new actor in allergic contact dermatitis 29
UVB-induced p53 is reduced by a mixture of natural extracts 29
Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators 27
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 26
Psoriasis, cardiovascular events, and biologics: Lights and shadows 26
Disseminated mucocutaneous Candida infection during anti IL-17A therapy in a psoriatic patient 26
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 24
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 24
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 23
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris 23
The role of the dermatologist in the immune-mediated/allergic diseases – position statement of the EADV task force on contact dermatitis, EADV task force on occupational skin diseases, UEMS-EBDV subcommission allergology and European Dermatology Forum 23
Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review 22
Guselkumab e psoriasi in sedi difficili: efficacia ed impatto sulla qualità di vita in pazienti naive o bio experienced 22
Psoriasi eritrodermica: rapida efficacia di bimekizumab 22
Polymorphic light eruption: What's new in pathogenesis and management 22
Psoriasiform dermatitis during dupilumab treatment in atopic patient resolved after combo-therapy with methotrexate 21
Psoriasi e terapia con guselkumab: panoramica 2022 dal centro prescrittore AOU Salerno 20
Limitations of current monoclonal antibodies for plaque-type psoriasis and an outlook for the future 20
New insights into mechanism of Notch signaling in hidradenitis suppurativa 19
Novel interactions among ultraviolet B, skin and adipose tissue 19
Systemic inflammation: psoriasis as a model…in Naples 19
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection 19
Ultrasonography in the management of a recurrent and eruptive lobular capillary hemangioma and resolution with intense pulsed light 18
Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb 17
Letters to the editor 17
Photodermatoses and Skin Cancer 17
Presence of BAG3 protein in serum samples from patients affected by psoriasis 16
Dermatite atopica e stress ossidativo: nuovi biomarker 16
Studio osservazionale descrittivo per la valutazione della prevalenza della psoriasi nei pazienti adulti dislipidemici in terapia monoclonale con anti-PCSK9 15
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 15
Sociodemographic, clinical and therapeutic factors as predictors of life quality impairment in psoriasis: A cross-sectional study in Italy 15
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study 14
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 14
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 14
Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study 11
Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy 11
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study 10
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study 9
Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series 8
Oxidative Stress in Atopic Dermatitis and Possible Biomarkers: Present and Future 7
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 6
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients 5
Totale 3.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.141
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 3 0 11 7 19 0 1 10 8 16
2021/2022255 2 4 3 20 30 2 0 11 21 5 40 117
2022/2023544 55 56 27 74 27 102 6 53 87 15 27 15
2023/2024541 23 54 39 26 35 45 28 46 18 66 54 107
2024/20251.533 65 36 115 137 79 187 169 86 240 88 145 186
2025/202637 37 0 0 0 0 0 0 0 0 0 0 0
Totale 3.104